Bailey Vasudev Jaiprakash 4

What Happened
Bailey Vasudev Jaiprakash, a director of Rani Therapeutics Holdings, Inc. (RANI), was granted a derivative award on May 28, 2026 covering 123,600 shares. The Form 4 reports an acquisition at $0.00 (transaction code A — award/grant). The filing identifies the award as shares subject to an option (see footnote).

Key Details

• Transaction date: 2026-05-28; Form 4 filed 2026-06-01 (timely — within 2 business days).
• Reported price: $0.00; transaction code: A (award/grant); reported as a derivative security.
• Shares in grant: 123,600 shares.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote (F1): The shares subject to the option vest in full on the first anniversary of the grant date, subject to the reporting person’s continuous service; alternatively, vesting occurs earlier upon the company’s next annual stockholder meeting or a Change in Control (each subject to continuous service).

Context
This was an equity award (a derivative/option grant), not an open-market purchase or sale. There was no immediate cash paid per the filing (reported price $0.00); the economic value to the insider depends on future vesting and the company’s stock price. Awards to directors are common compensation and do not by themselves indicate the insider’s intent to buy or sell shares.